
---
title: '午间公告：安科生物人生长激素注射液申请获批'
categories: 
 - 金融
 - 证券时报网
 - 快讯
headimg: 'https://picsum.photos/400/300?random=251'
author: 证券时报网
comments: false
date: Thu, 30 Dec 2021 12:04:00 GMT
thumbnail: 'https://picsum.photos/400/300?random=251'
---

<div>   
<p>证券时报e公司讯，<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SZ300009" style="color: #2f67d1;text-decoration: none;" code="300009" target="_blank">安科生物</a>：人生长激素注射液获药品补充申请批准通知书；<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SZ002262" style="color: #2f67d1;text-decoration: none;" code="002262" target="_blank">恩华药业</a>：注射用盐酸瑞芬太尼增加适应症获得药物临床试验批准通知书；<a class="trsHotWords" href="http://info.stcn.com/dc/stock/?stockcode=SZ002937" style="color: #2f67d1;text-decoration: none;" code="002937" target="_blank">兴瑞科技</a>：拟以评估价格831万元向关联方慈溪骏瑞购买工业房地产。</p>

                  
</div>
            